Personalised medicine will make drug experimentation on populations the norm
In June 2023, the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”) announced it will be the first drug safety regulator in the world to pilot its own genetic “biobank,” to better understand how a patient’s genetic makeup can impact the safety of their medicines.
“The Yellow Card